Stocks / AXON vs BWMN

Axovant Sciences Ltd. Common Shares (AXON) vs Bowman Consulting Group Ltd. (BWMN)

Axovant Sciences Ltd. Common Shares and Bowman Consulting Group Ltd. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.

AXON is the larger company ($51.0B vs $0.5B). On the fundamentals, AXON grows revenue faster (32.5% vs 32.1%); AXON earns a higher net margin (4.5% vs 2.6%); BWMN has the stronger return on equity (4.9% vs 3.8%). Over the last five years, AXON returned 230.3% vs 125.7%. On the filings, BWMN carries fewer potential red flags (2 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AXON vs BWMN, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Axovant Sciences Ltd. Common Shares (AXON)Bowman Consulting Group Ltd. (BWMN)
Market cap$51.0B$0.5B
Revenue (latest FY)$2.78B$490.02M
Net income (latest FY)$124.66M$12.85M
Revenue growth (5y CAGR)32.5%32.1%
Net margin4.5%2.6%
Return on equity3.8%4.9%
P/E ratio262.750.4
Dividend yield
Profitable years (of last 10)85
Positive free cash flowYesYes

Performance — AXON vs BWMN

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Axovant Sciences Ltd. Common Shares (AXON)Bowman Consulting Group Ltd. (BWMN)
1-year return-19.6%8.7%
3-year return182.2%-2.0%
5-year return230.3%125.7%
10-year return2118.4%
52-week range$339.01–$792.16$25.96–$45.83

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AXON vs BWMN breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AXON's full financials →   Open BWMN's full financials →

More comparisons

Frequently asked questions

Which is bigger, AXON or BWMN?

Axovant Sciences Ltd. Common Shares is larger by market capitalization — $51.0B versus $0.5B.

Which grows faster, AXON or BWMN?

Over the last five fiscal years, Axovant Sciences Ltd. Common Shares grew revenue faster — 32.5%/yr versus 32.1%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AXON fundamentals → · BWMN fundamentals → · All 1,500+ companies → · Free screener →